SavedAdd your journal

Journals / Epilepsi / 2017 / Cilt: 23 - Sayı: 1

Status Epilepticus Associated with Ecstasy

Ekstazi İlişkili Status Epileptikus

Oğuzhan ÖZ
Ahmet ÇETİZ
Serdar TAŞDEMİR
Hakan AKGÜN
Muammer KORKMAZ
Salim Kemal TUNCER
Mehmet YÜCEL
ŞEREF DEMİRKAYA
Journal
Epilepsi
Pages
31–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presently described is case of recurrent status epilepticus in which ecstasy was thought to be an etiological factor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Status epilepticus is a life-threating emergency situation.
📊
Key Findings & Data:Ecstasy (3,4-methylenedioxymethamphetamine) is an amphetamine derivate known to cause status epilepticus.
💡
Conclusion & Impact:Presently described is case of recurrent status epilepticus in which ecstasy was thought to be an etiological factor.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Status epilepticus is a life-threating emergency situation. In addition to well-known etiological factors, many rare causative factors have also been defined. Ecstasy (3,4-methylenedioxymethamphetamine) is an amphetamine derivate known to cause status epilepticus. Presently described is case of recurrent status epilepticus in which ecstasy was thought to be an etiological factor.

Özet

Status epileptikus hayatı tehdit edebilen bir acil durumdur. İyi bilinen sık etiyolojik faktörlerin yanı sıra nadiren görülebilen birçok neden tanımlanmıştır. Ekstazi (3,4-methylenedioxymethamphetamine) bir amfetamin türevidir ve status epileptikusa neden olduğu bilinmektedir. Bu yazıda, tekrarlayan status epileptikus tablosu gelişen ve etiyolojisinde ekstazinin sorumlu tutulduğu bir olgu sunuldu.

🔖

Cite This Article

ÖZ, O., ÇETİZ, A., TAŞDEMİR, S., AKGÜN, H., KORKMAZ, M., TUNCER, S. K., YÜCEL, M., DEMİRKAYA, Ş. (2017). Status Epilepticus Associated with Ecstasy. Epilepsi, Cilt: 23 - Sayı: 1, 31–34. https://ajindex.com/articles/158358

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Peters NF, Gosselin R, Verstraete KL. A rare case of diffuse alve-olar hemorrhage following oral amphetamine intake. JBR-BTR 2014;97(1):42–3
  2. Francesconi G, Orsolini L, Papanti D, Corkery JM, Schifano F. Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web-based misusers’ experiences. Hum Psychop-harmacol 2015;30(4):255–61
  3. Brown JW, Dunne JW, Fatovich DM, Lee J, Lawn ND. Ampheta-mine-associated seizures: clinical features and prognosis. Epi-lepsia 2011;52(2):401–4
  4. Giorgi FS, Lazzeri G, Natale G, Iudice A, Ruggieri S, Paparelli A, et al. MDMA and seizures: a dangerous liaison? Ann N Y Acad Sci 2006;1074:357–64
  5. Landry MJ. MDMA: a review of epidemiologic data. J Psychoac-tive Drugs 2002;34(2):163–9
  6. Leach JP, Mohanraj R, Borland W. Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention. Epilepsia 2012;53 Suppl 4:48–57
  7. Green AR, O’shea E, Colado MI. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 2004;500(1-3):3–13
  8. Tan RY, Neligan A, Shorvon SD. The uncommon causes of sta-tus epilepticus: a systematic review. Epilepsy Res 2010;91(2-3):111–22
  9. Maxwell JC. Are we becoming more alike? Comparison of subs-tance use in Australia and the United States as seen in the 1995, 1998, 2001 and 2004 national household surveys. Drug Alcohol Rev 2008;27(5):473–81
  10. Chin RF, Neville BG, Scott RC. A systematic review of the epide-miology of status epilepticus. Eur J Neurol 2004;11(12):800–10.